Inventor · disambiguated record
Kurt Hertogs
Also filed as: HERTOGS KURT
11 granted patents·6 pending applications·131 citations·filing 1997–2009
89Inventor score
Files withVIRCO NV5TIBOTEC PHARM LTD3DEHERTOGH PASCALE ALFONS ROSA1HERTOGS KURT1KESTELEYN BART RUDOLF ROMANIE1
Top patents by PatentIndex Score
17 records- 0185US7292944B2Establishment of biological cut-off values for predicting resistance to therapyVIRCO BVBA·Filed 2001·Granted Nov 6, 2007·43 cites·12 claims
- 0279US7442705B2HIV replication inhibiting pyrimidines and triazinesTIBOTEC PHARM LTD·Filed 2004·Granted Oct 28, 2008·12 cites·11 claims
- 0379US7206699B2Methods for measuring therapy resistanceVIRCO NV·Filed 2001·Granted Apr 17, 2007·15 cites·23 claims
- 0478US6528251B2Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsVIRCO NV·Filed 2000·Granted Mar 4, 2003·13 cites·12 claims
- 0570US7585870B2HIV replication inhibiting pyrimidines and triazinesTIBOTEC BVBA·Filed 2004·Granted Sep 8, 2009·4 cites·11 claims
- 0668US6221578B1Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsVIRCO NV·Filed 1997·Granted Apr 24, 2001·28 cites·24 claims
- 0763US8563236B2Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistanceHERTOGS KURT·Filed 2009·Granted Oct 22, 2013·0 cites·1 claims
- 0859US8574831B2Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistanceDEHERTOGH PASCALE ALFONS ROSA·Filed 2007·Granted Nov 5, 2013·0 cites·2 claims
- 0958US7494768B1Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistanceTIBOTEC VIRCO VIROLOGY BVBA·Filed 2000·Granted Feb 24, 2009·15 cites·1 claims
- 1055US7608726B2Substituted indolepyridinium as anti-infective compoundsTIBOTEC PHARM LTD·Filed 2003·Granted Oct 27, 2009·1 cites·17 claims
- 1154US2004073378A1Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistanceFiled 2001·Application pending·0 cites
- 1251US2010048563A1Substituted indolepyridinium as anti-infective compoundsKESTELEYN BART RUDOLF ROMANIE·Filed 2009·Application pending·0 cites
- 1348US2003152917A1Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsVIRCO NV·Filed 2003·Application pending·0 cites
- 1447US2007166747A1Methods for Measuring Therapy ResistanceVIRCO NV·Filed 2007·Application pending·0 cites
- 1543US2008234288A1Hcv Inhibiting SulfonamidesSIMMEN KENNETH ALAN·Filed 2004·Application pending·0 cites
- 1643US2006286547A1Time-of-addition assay for identifying anti-viral compoundsVAN ACKER KOENRAAD L A·Filed 2004·Application pending·0 cites
- 1736US7429677B2Small molecule entry inhibitorsTIBOTEC PHARM LTD·Filed 2003·Granted Sep 30, 2008·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Kurt Hertogs files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →